Supplement
Hesperidin is a flavonoid found in citrus fruit, especially oranges, that works as an antioxidant and may influence how blood vessels behave. In a small trial, apolipoprotein B, a cholesterol-carrying protein, improved, with moderate evidence, and blood flow went up in a study of nine people. Blood glucose showed no clear difference, and most findings come from small studies.
Sources: PMID 22307524
- Updated
- How we grade
- 12 studies cited
- Best evidence
- Grade B
- Conditions studied
- 9
- Outcomes
- 99
- Graded outcomes
- 0118
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein B Small Improvement | Improves (the measure goes down) | Small effect | 65 people | |||
| Blood glucose No effect | NoneNo effect | 2 studies | 705 people | |||
Studies that measured blood glucose | ||||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 4 studies | 525 people | |||
Studies that measured low-density lipoprotein (ldl)
| ||||||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 525 people | |||
Studies that measured total cholesterol
| ||||||
| Blood Pressure | Improves (the measure goes down) | 338 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 569 people | ||||
| Insulin | Changes; see studies | 302 people | ||||
| LDL Oxidation | Improves (the measure goes down) | 25 people | ||||
| Liver Enzymes | Changes; see studies | 25 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 241 people | ||||
| Triglycerides | Improves (the measure goes down) | 569 people | ||||
| Waist circumference | Improves (the measure goes down) | 116 people | ||||
| Weight | Improves (the measure goes down) | 457 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Moderate Increase | Improves (the measure goes up) | Moderate effect | 1 study | 9 people | ||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 4 studies | 24 people | |||
Studies that measured low-density lipoprotein (ldl)
| ||||||
| Blood glucose | Improves (the measure goes down) | 2 studies | 24 people | |||
Studies that measured blood glucose | ||||||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 24 people | |||
Studies that measured total cholesterol
| ||||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 24 people | |||
Studies that measured c-reactive protein (crp) | ||||||
| Blood Pressure | Improves (the measure goes down) | 24 people | ||||
| Cell Adhesion Factors | Improves (the measure goes down) | 24 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 24 people | ||||
| Insulin | Changes; see studies | 24 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 24 people | ||||
| Microcirculation | Improves (the measure goes up) | 24 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 24 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 24 people | ||||
| Triglycerides | Improves (the measure goes down) | 24 people | ||||
Metabolic Health
- Blood glucose
- Low-density lipoprotein (LDL): improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 2 studies | 1,023 people | |||
Studies that measured blood glucose | ||||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 4 studies | 525 people | |||
Studies that measured low-density lipoprotein (ldl)
| ||||||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 525 people | |||
Studies that measured total cholesterol
| ||||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 296 people | |||
Studies that measured c-reactive protein (crp) | ||||||
| Blood Pressure | Improves (the measure goes down) | 338 people | ||||
| HbA1c | Improves (the measure goes down) | 318 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 569 people | ||||
| Insulin | Changes; see studies | 318 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 318 people | ||||
| Intercellular Adhesion Molecule 1 | Changes; see studies | 296 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 296 people | ||||
| sE-Selectin | Improves (the measure goes up) | 296 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 241 people | ||||
| Triglycerides | Improves (the measure goes down) | 569 people | ||||
| Vascular Adhesion Protein-1 | Improves (the measure goes up) | 296 people | ||||
| Waist circumference | Improves (the measure goes down) | 116 people | ||||
| Weight | Improves (the measure goes down) | 457 people | ||||
General Cardiovascular Health
- Blood glucose
- Low-density lipoprotein (LDL): improves
- Total cholesterol: improves
Type 2 Diabetes
- Blood glucose
- HbA1c: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 2 studies | 318 people | |||
Studies that measured blood glucose | ||||||
| HbA1c | Improves (the measure goes down) | 318 people | ||||
| Insulin | Changes; see studies | 318 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 318 people | ||||
Cardiovascular Disease
- Blood glucose
- Low-density lipoprotein (LDL): improves
- Total cholesterol: improves
Rheumatoid Arthritis (RA)
- C-Reactive Protein (CRP)
- Rheumatoid Arthritis Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 1 study | 19 people | |||
Studies that measured c-reactive protein (crp) | ||||||
| Rheumatoid Arthritis Symptoms | Improves (the measure goes down) | 1 study | 19 people | |||
Studies that measured rheumatoid arthritis symptoms | ||||||
Immune Health
- B Cell Count
- C-Reactive Protein (CRP): improves
- Neutrophil Count: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect | NoneNo effect | 24 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 296 people | |||
Studies that measured c-reactive protein (crp) | ||||||
| Neutrophil Count | Improves (the measure goes up) | 1 study | 24 people | |||
Studies that measured neutrophil count | ||||||
| Intercellular Adhesion Molecule 1 | Changes; see studies | 296 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 296 people | ||||
| Natural Killer Cell Activity | Improves (the measure goes up) | 24 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 24 people | ||||
| Neutrophil Activity | Improves (the measure goes up) | 24 people | ||||
| sE-Selectin | Improves (the measure goes up) | 296 people | ||||
| T Cell Count | Improves (the measure goes up) | 24 people | ||||
| Vascular Adhesion Protein-1 | Improves (the measure goes up) | 296 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 24 people | ||||
Metabolic Syndrome
- Apolipoprotein A
- Low-density lipoprotein (LDL): improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A No effect | NoneNo effect | 24 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 4 studies | 24 people | |||
Studies that measured low-density lipoprotein (ldl)
| ||||||
| Blood glucose | Improves (the measure goes down) | 2 studies | 24 people | |||
Studies that measured blood glucose | ||||||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 24 people | |||
Studies that measured total cholesterol
| ||||||
| Blood Flow | Improves (the measure goes up) | 1 study | 24 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 24 people | |||
| Apolipoprotein B | Improves (the measure goes down) | 24 people | ||||
| Blood Pressure | Improves (the measure goes down) | 24 people | ||||
| Cell Adhesion Factors | Improves (the measure goes down) | 24 people | ||||
| Fibrinogen | Improves (the measure goes up) | 24 people | ||||
| Glycemic Control | Improves (the measure goes up) | 24 people | ||||
| HbA1c | Improves (the measure goes down) | 24 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 24 people | ||||
| Homocysteine | Improves (the measure goes down) | 24 people | ||||
| Insulin | Changes; see studies | 24 people | ||||
| Triglycerides | Improves (the measure goes down) | 24 people | ||||
| Weight | Improves (the measure goes down) | 24 people | ||||
Key findings
- Apolipoprotein BImproves (the measure goes down)
- Blood FlowImproves (the measure goes up)
- Blood glucose
Shop the evidence-backed picks
Third-party tested Hesperidin products, in the forms the graded studies used where we can match them.
- Grade B
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
12 studies from PubMed
- Bioavailability of orally administered water-dispersible hesperetin and its effect on peripheral vasodilatation in human subjects: implication of endothelial functions of plasma conjugated metabolites
- Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers
- The effects of hesperidin supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis.
- Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality
- Effects of glucosyl hesperidin on serum lipids in hyperlipidemic subjects: preferential reduction in elevated serum triglyceride level
- The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women
- Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome
- Hesperidin, a major flavonoid in orange juice, might not affect lipid profile and blood pressure: A systematic review and meta-analysis of randomized controlled clinical trials
- Effects of alpha-glucosylhesperidin, a bioactive food material, on collagen-induced arthritis in mice and rheumatoid arthritis in humans
- Orange juice and its major polyphenol hesperidin consumption do not induce immunomodulation in healthy well-nourished humans
- The effect of hesperidin supplementation on inflammatory markers in human adults: A systematic review and meta-analysis of randomized controlled clinical trials.
- Hesperidin supplementation has no effect on blood glucose control: A systematic review and meta-analysis of randomized controlled clinical trials.